General Information of Drug Transporter (DT)
DT ID DTD0045 Transporter Info
Gene Name ABCA7
Transporter Name ATP-binding cassette sub-family A member 7
Gene ID
10347
UniProt ID
Q8IZY2
Post-Translational Modification of This DT
Overview of ABCA7 Modification Sites with Functional and Structural Information
Sequence
MAFWTQLMLL LWKNFMYRRR QPVQLLVELL WPLFLFFILV AVRHSHPPLE HHECHFPNKP 
LPSAGTVPWL QGLICNVNNT CFPQLTPGEE PGRLSNFNDS LVSRLLADAR TVLGGASAHR 
TLAGLGKLIA TLRAARSTAQ PQPTKQSPLE PPMLDVAELL TSLLRTESLG LALGQAQEPL 
HSLLEAAEDL AQELLALRSL VELRALLQRP RGTSGPLELL SEALCSVRGP SSTVGPSLNW 
YEASDLMELV GQEPESALPD SSLSPACSEL IGALDSHPLS RLLWRRLKPL ILGKLLFAPD 
TPFTRKLMAQ VNRTFEELTL LRDVREVWEM LGPRIFTFMN DSSNVAMLQR LLQMQDEGRR 
QPRPGGRDHM EALRSFLDPG SGGYSWQDAH ADVGHLVGTL GRVTECLSLD KLEAAPSEAA 
LVSRALQLLA EHRFWAGVVF LGPEDSSDPT EHPTPDLGPG HVRIKIRMDI DVVTRTNKIR 
DRFWDPGPAA DPLTDLRYVW GGFVYLQDLV ERAAVRVLSG ANPRAGLYLQ QMPYPCYVDD 
VFLRVLSRSL PLFLTLAWIY SVTLTVKAVV REKETRLRDT MRAMGLSRAV LWLGWFLSCL 
GPFLLSAALL VLVLKLGDIL PYSHPGVVFL FLAAFAVATV TQSFLLSAFF SRANLAAACG 
GLAYFSLYLP YVLCVAWRDR LPAGGRVAAS LLSPVAFGFG CESLALLEEQ GEGAQWHNVG 
TRPTADVFSL AQVSGLLLLD AALYGLATWY LEAVCPGQYG IPEPWNFPFR RSYWCGPRPP 
KSPAPCPTPL DPKVLVEEAP PGLSPGVSVR SLEKRFPGSP QPALRGLSLD FYQGHITAFL 
GHNGAGKTTT LSILSGLFPP SGGSAFILGH DVRSSMAAIR PHLGVCPQYN VLFDMLTVDE 
HVWFYGRLKG LSAAVVGPEQ DRLLQDVGLV SKQSVQTRHL SGGMQRKLSV AIAFVGGSQV 
VILDEPTAGV DPASRRGIWE LLLKYREGRT LILSTHHLDE AELLGDRVAV VAGGRLCCCG 
SPLFLRRHLG SGYYLTLVKA RLPLTTNEKA DTDMEGSVDT RQEKKNGSQG SRVGTPQLLA 
LVQHWVPGAR LVEELPHELV LVLPYTGAHD GSFATLFREL DTRLAELRLT GYGISDTSLE 
EIFLKVVEEC AADTDMEDGS CGQHLCTGIA GLDVTLRLKM PPQETALENG EPAGSAPETD 
QGSGPDAVGR VQGWALTRQQ LQALLLKRFL LARRSRRGLF AQIVLPALFV GLALVFSLIV 
PPFGHYPALR LSPTMYGAQV SFFSEDAPGD PGRARLLEAL LQEAGLEEPP VQHSSHRFSA 
PEVPAEVAKV LASGNWTPES PSPACQCSRP GARRLLPDCP AAAGGPPPPQ AVTGSGEVVQ 
NLTGRNLSDF LVKTYPRLVR QGLKTKKWVN EVRYGGFSLG GRDPGLPSGQ ELGRSVEELW 
ALLSPLPGGA LDRVLKNLTA WAHSLDAQDS LKIWFNNKGW HSMVAFVNRA SNAILRAHLP 
PGPARHAHSI TTLNHPLNLT KEQLSEGALM ASSVDVLVSI CVVFAMSFVP ASFTLVLIEE 
RVTRAKHLQL MGGLSPTLYW LGNFLWDMCN YLVPACIVVL IFLAFQQRAY VAPANLPALL 
LLLLLYGWSI TPLMYPASFF FSVPSTAYVV LTCINLFIGI NGSMATFVLE LFSDQKLQEV 
SRILKQVFLI FPHFCLGRGL IDMVRNQAMA DAFERLGDRQ FQSPLRWEVV GKNLLAMVIQ 
GPLFLLFTLL LQHRSQLLPQ PRVRSLPLLG EEDEDVARER ERVVQGATQG DVLVLRNLTK 
VYRGQRMPAV DRLCLGIPPG ECFGLLGVNG AGKTSTFRMV TGDTLASRGE AVLAGHSVAR 
EPSAAHLSMG YCPQSDAIFE LLTGREHLEL LARLRGVPEA QVAQTAGSGL ARLGLSWYAD 
RPAGTYSGGN KRKLATALAL VGDPAVVFLD EPTTGMDPSA RRFLWNSLLA VVREGRSVML 
TSHSMEECEA LCSRLAIMVN GRFRCLGSPQ HLKGRFAAGH TLTLRVPAAR SQPAAAFVAA 
EFPGAELREA HGGRLRFQLP PGGRCALARV FGELAVHGAE HGVEDFSVSQ TMLEEVFLYF 
SKDQGKDEDT EEQKEAGVGV DPAPGLQHPK RVSQFLDDPS TAETVL
PTM type
X-N-glycosylation X-O-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCA7 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

312

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at ABCA7 Asparagine 312 has the potential to affect its expression or activity.

O-glycosylation

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCA7 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

555

Experimental Method

Co-Immunoprecipitation

Detailed Description

O-linked Glycosylation at ABCA7 Threonine 555 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        16 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCA7 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

147

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 147 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCA7 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

162

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 162 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence ABCA7 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

182

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 182 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence ABCA7 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

199

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 199 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence ABCA7 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

519

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 519 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence ABCA7 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

804

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 804 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence ABCA7 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

934

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 934 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence ABCA7 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

941

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 941 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence ABCA7 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

949

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 949 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence ABCA7 [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

958

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 958 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence ABCA7 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1314

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 1314 has the potential to affect its expression or activity.

  PTM Phenomenon 12

Have the potential to influence ABCA7 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1315

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 1315 has the potential to affect its expression or activity.

  PTM Phenomenon 13

Have the potential to influence ABCA7 [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1342

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 1342 has the potential to affect its expression or activity.

  PTM Phenomenon 14

Have the potential to influence ABCA7 [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1908

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 1908 has the potential to affect its expression or activity.

  PTM Phenomenon 15

Have the potential to influence ABCA7 [10] , [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1916

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 1916 has the potential to affect its expression or activity.

  PTM Phenomenon 16

Have the potential to influence ABCA7 [13] , [14]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2133

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Serine 2133 has the potential to affect its expression or activity.

  Threonine

        11 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCA7 [15]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

144

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Threonine 144 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCA7 [16]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

450

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Threonine 450 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence ABCA7 [16]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

454

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Threonine 454 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence ABCA7 [17]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

580

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Threonine 580 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence ABCA7 [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

937

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Threonine 937 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence ABCA7 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1175

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Threonine 1175 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence ABCA7 [1]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1405

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Threonine 1405 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence ABCA7 [1]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1748

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Threonine 1748 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence ABCA7 [1]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1844

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Threonine 1844 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence ABCA7 [10] , [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1905

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Threonine 1905 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence ABCA7 [10]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1925

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Threonine 1925 has the potential to affect its expression or activity.

  Tyrosine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCA7 [1]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

528

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Tyrosine 528 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCA7 [18]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1033

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Tyrosine 1033 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence ABCA7 [18]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1034

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Tyrosine 1034 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence ABCA7 [12]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1918

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA7 Tyrosine 1918 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCA7 [19]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

932

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at ABCA7 Lysine 932 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: ABCA7_HUMAN)
2 Mapping and Quantification of Over 2000 O-linked Glycopeptides in Activated Human T Cells with Isotope-Targeted Glycoproteomics (Isotag). Mol Cell Proteomics. 2018 Apr;17(4):764-775.
3 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
4 Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.
5 Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
6 Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 2014 Sep 11;8(5):1583-94.
7 Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa. Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S118-S131.
8 New opportunities for researchers in obstetrics and gynecology through programs supported by the National Institute of Child Health and Human Development. Am J Obstet Gynecol. 1999 Jul;181(1):221-5.
9 The use of NSAIDs in asthmatic children: a questionnaire survey. Paediatr Anaesth. 1999;9(4):369-70.
10 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
11 Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal. 2013 Mar 26;6(268):rs6.
12 An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
13 Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
14 Differential Factors in Fume Fever. Arch Bronconeumol (Engl Ed). 2019 Sep;55(9):451-452.
15 A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples. J Proteome Res. 2012 Nov 2;11(11):5311-22.
16 Fast Global Phosphoproteome Profiling of Jurkat T Cells by HIFU-TiO2-SCX-LC-MS/MS. Anal Chem. 2017 Sep 5;89(17):8853-8862.
17 TiO2 with Tandem Fractionation (TAFT): An Approach for Rapid, Deep, Reproducible, and High-Throughput Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):710-721.
18 A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
19 New findings on essential amino acids. Cesk Fysiol. 1990;39(1):13-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.